Anti-inflammatory agent 41
Anti-inflammatory agent 41 (13a) significantly inhibit lipopolysaccharide (LPS)-induced expression of the proinflammatory cytokines IL-6 and TNF-α on J774A.1, THP-1 and LX-2 cells, and inhibits the activation of the NF-κB pathway.
For research use only. We do not sell to patients.
- CAS No.: 2896204-90-1
- Formula: C33H25N3O5
- Molecular Weight:543.57
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| J774.A1 | IC50 |
1.332 μM
Compound: 13a
|
Antiinflammatory activity in LPS-induced mouse J774.A1 cells assessed as inhibition of LPS-induced IL-6 release preincubated for 30 mins followed by LPS stimulation for 24 hrs by ELISA method
Antiinflammatory activity in LPS-induced mouse J774.A1 cells assessed as inhibition of LPS-induced IL-6 release preincubated for 30 mins followed by LPS stimulation for 24 hrs by ELISA method
|
[PMID: 36708679] |
| J774.A1 | IC50 |
2.403 μM
Compound: 13a
|
Antiinflammatory activity in LPS-induced mouse J774.A1 cells assessed as inhibition of LPS-induced TNF-alpha release preincubated for 30 mins followed by LPS stimulation for 24 hrs by ELISA method
Antiinflammatory activity in LPS-induced mouse J774.A1 cells assessed as inhibition of LPS-induced TNF-alpha release preincubated for 30 mins followed by LPS stimulation for 24 hrs by ELISA method
|
[PMID: 36708679] |
| LX-2 | IC50 |
2.625 μM
Compound: 13a
|
Antiinflammatory activity in LPS-induced human LX2 cells assessed as inhibition of LPS-induced IL-6 release preincubated for 30 mins followed by LPS stimulation for 24 hrs by ELISA method
Antiinflammatory activity in LPS-induced human LX2 cells assessed as inhibition of LPS-induced IL-6 release preincubated for 30 mins followed by LPS stimulation for 24 hrs by ELISA method
|
[PMID: 36708679] |
| LX-2 | IC50 |
2.908 μM
Compound: 13a
|
Antiinflammatory activity in LPS-induced human LX2 cells assessed as inhibition of LPS-induced TNF-alpha release preincubated for 30 mins followed by LPS stimulation for 24 hrs by ELISA method
Antiinflammatory activity in LPS-induced human LX2 cells assessed as inhibition of LPS-induced TNF-alpha release preincubated for 30 mins followed by LPS stimulation for 24 hrs by ELISA method
|
[PMID: 36708679] |
| THP-1 | IC50 |
1.328 μM
Compound: 13a
|
Antiinflammatory activity in LPS-induced human THP-1 cells assessed as inhibition of LPS-induced IL-6 release preincubated for 30 mins followed by LPS stimulation for 24 hrs by ELISA method
Antiinflammatory activity in LPS-induced human THP-1 cells assessed as inhibition of LPS-induced IL-6 release preincubated for 30 mins followed by LPS stimulation for 24 hrs by ELISA method
|
[PMID: 36708679] |
| THP-1 | IC50 |
1.667 μM
Compound: 13a
|
Antiinflammatory activity in LPS-induced human THP-1 cells assessed as inhibition of LPS-induced TNF-alpha release preincubated for 30 mins followed by LPS stimulation for 24 hrs by ELISA method
Antiinflammatory activity in LPS-induced human THP-1 cells assessed as inhibition of LPS-induced TNF-alpha release preincubated for 30 mins followed by LPS stimulation for 24 hrs by ELISA method
|
[PMID: 36708679] |
In Vitro
Anti-inflammatory agent 41 (13a) significantly reduced the LPS-induced nuclear translocation of p65 in J774A.1 macrophages[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 2896204-90-1
-
Molecular Weight 543.57
-
Formula C33H25N3O5
-
SMILES
COC1=CC2=C(C(OC3=CC=C(C=C3)NC(C4=CN(C5=CC=CC=C5C4=O)C6=CC=CC=C6)=O)=CC=N2)C=C1OC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)